Theolytics

📍 Oxford, United Kingdom🗓 Founded 2017👥 34 employees💰 Last funded May 2023
Biotechnology Research🌐 theolytics.com
Website LinkedIn
Theolytics is a biotechnology company harnessing viruses to combat cancer. A step-change in the oncolytic viral therapy field, our phenotypic screening Platform enables the discovery and development of efficacious, targeted candidates suitable for intravenous delivery and optimised for a chosen patient population. In addition to advancing an internal Pipeline of programs spanning both solid and liquid tumours, we are establishing select strategic partnerships to expand and accelerate pipeline development.
1
Total investors
0
Early stage
0
Mid stage
1
Late stage
2017
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Israel
1
Frequently asked questions
Who invested in Theolytics?
Theolytics has 1 investors on record on gritt.io and 1 late-stage investors.
When did Theolytics last raise funding?
The most recent investment in Theolytics recorded on gritt.io was in May 2023.
When was Theolytics founded?
Theolytics was founded in 2017.
What industry is Theolytics in?
Theolytics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Theolytics based?
Theolytics is headquartered in Oxford, United Kingdom.